Reduced prescription of TNF|inhibitors in chronic arthritis based on ...

Reduced prescription of TNF-inhibitors in chronic arthritis based on ...

TDM reduced prescription of IFX, ETN, and ADA and identified patients benefiting from accelerated drug switch, thereby minimizing treatment ...

Reduced prescription of TNF-inhibitors in chronic arthritis based on ...

TDM reduced prescription of IFX, ETN, and ADA and identified patients benefiting from accelerated drug switch, thereby minimizing treatment failure.

Reduced prescription of TNF-inhibitors in chronic arthritis based on ...

Dosing of tumour necrosis factor-α inhibitors (TNFis) is not personalized causing interindividual variation in serum drug levels; however, dose ...

Reduced Prescription of TNF-Inhibitors in Patients With Chronic ...

The study included 239 patients with inflammatory arthritis on TNF inhibitors: 99 with rheumatoid arthritis, 48 with psoriatic arthritis, and 92 ...

Low rates of adherence for tumor necrosis factor-α inhibitors in ...

Clinical effectiveness of TNF-α inhibitors is dependent on adequate adherence, and failure to stick to the prescribed drug regimen contributes to failure of ...

Predictors of tumor necrosis factor inhibitors primary failure in ...

Tumor necrosis factor inhibitors (TNFi) have emerged as an efficient therapeutic modality for rheumatoid arthritis (RA).

Disease activity–guided dose optimization including discontinuation ...

In conclusion, over a period of 10 years, disease activity–guided dose optimization of TNF inhibitors in RA leads to significant dose reduction ...

Methotrexate Reduces the Probability of Discontinuation of TNF ...

Tumor necrosis factor inhibitors (TNFi) are widely used for the treatment of patients with rheumatoid arthritis (RA), who do not respond to ...

What Happens When an Anti-TNF Fails for RA - Arthritis Foundation

Smoking, more-severe disease, older age and genetic changes also play a part. If patients don't respond to an anti-TNF medication, they have two ...

Reduced prescription of TNF-inhibitors in chronic arthritis based on ...

Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial.

Discontinuation rates of biologics in patients with rheumatoid arthritis

TNFi had lower discontinuation rates than non-TNFi after propensity score adjustment: HR for first biologic 0.49 (0.34 to 0.71) and 0.68 (0.51 to 0.90) for ...

Personalized Dose Reduction Based on Serum TNF-Inhibitors ...

Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A... ... Objective: Dosing of tumour necrosis factor-α ...

Estimation of optimal adherence threshold for tumor necrosis factor ...

The objective of the study was to determine the optimal threshold of the proportion of days covered (PDC) for tumor necrosis factor (TNF) ...

Tumor Necrosis Factor (TNF) blocking agents are associated ... - PLOS

Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis · Database ...

Retention rate of subcutaneous TNF inhibitors in axial ... - Nature

TNFi can be prescribed intravenously (IV) or subcutaneously (SC). Currently approved SC-TNFis for axSpA treatment are adalimumab (ADA), ...

OP0088 INITIATING TNF INHIBITORS IN INFLAMMATORY ...

Background: TNFα-inhibitor (TNFi) therapy is effective in controlling several rheumatic diseases and has been shown to reduce pain in patients with arthritis.

Use of TNF Inhibitors in Rheumatoid Arthritis and Implications for the ...

Etanercept is a recombinant fusion drug existing of TNF p75 receptor and the fc component of human IgG1. Anti-TNF reduces inflammatory reaction ...

Managing inadequate response to initial anti-TNF therapy in ...

Anti-tumour necrosis factors (anti-TNFs) are established as first-line biological therapy for rheumatoid arthritis (RA) with over two decades of accumulated ...

Medicare Coverage of Tumor Necrosis Factor α Inhibitors as an ...

Tumor necrosis factor α inhibitors, such as etanercept and infliximab, have revolutionized the treatment of rheumatoid arthritis by averting ...

TNF Inhibitor Drugs: Autoimmune Disease Treatments - WebMD

TNF inhibitors are drugs that help stop inflammation. They're used to treat diseases like rheumatoid arthritis (RA), juvenile arthritis, psoriatic arthritis, ...